C3.ai is a distressed enterprise-AI pioneer: a defense-grade Federal moat and large cash cushion versus shrinking commercial revenue, collapsing margins, and a make-or-break execution reset under new leadership.
Overview
C3.ai (NYSE: AI) sits at a defining inflection point in late 2025: a marquee “pure-play AI” ticker with defense-grade validation and a large cash cushion, yet facing deteriorating fundamentals during the broad AI boom. FY26 has been marked by leadership upheaval (founder Thomas Siebel stepping down as CEO in Sept 2025 due to health issues; Stephen Ehikian appointed), repeated guidance cuts, and a disruptive sales/services restructuring that contributed to stalled deal conversion. Financial performance has decoupled from AI peers: FY25 revenue was ~$389M, but FY26 guidance is ~$289.5M–$309.5M (implying a ~20–25% contraction), and gross margins have compressed sharply (Q2 FY26 GAAP gross margin ~40%). The investment paradox is stark: C3.ai’s Federal business—anchored by the USAF PANDA system of record and FedRAMP credentials—creates real moat-like attributes and strategic value, while the commercial segment struggles amid consumption-model transition, partner concentration (notably Baker Hughes), and intensifying competition from hyperscalers and modern data platforms. With ~ $675M in cash and an EV/Sales near ~4.4x at ~$14.50/share, the stock reads as a distressed turnaround with embedded option value rather than a clean AI growth compounder.